B.Riley Starts PDS Biotechnology Corp (PDSB) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- S&P 500 futures steady after midterm rally; Nasdaq lags on chip weakness
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts PDSB Hot Sheet
Price: $1.30 --0%
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 31 | New: 5
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 31 | New: 5
Join SI Premium – FREE
B.Riley initiates coverage on PDS Biotechnology Corp (NASDAQ: PDSB) with a Buy rating and a price target of $10.00.
For an analyst ratings summary and ratings history on PDS Biotechnology Corp click here. For more ratings news on PDS Biotechnology Corp click here.
Shares of PDS Biotechnology Corp closed at $5.24 yesterday.
You May Also Be Interested In
- Citi initiates ATI Inc. coverage with Buy rating, $229 target
- H.C. Wainwright Assumes MiNK Therapeutics (INKT) at Buy
- Jones Trading Assumes Editas Medicine (EDIT) at Buy
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
